Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 43INDUSTRY 12OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Small Cell Lung Carcinoma 4Ovarian Neoplasms 3Stomach Neoplasms 2Solid Tumor 2Gastric Adenocarcinoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Two Different Treatment Methods 1Squamous Cell Carcinoma of Head and Neck 1Osteosarcoma 1Mucosal Melanoma 1Melanoma 1Immunotherapy Gastrict Cancer 1Immunotherapy 1HER-2 Negatived Gastric Cancer 1Carcinoma, Ovarian Epithelial 1Advanced Triple Negative Breast Cancer 1Advanced Metastatic Gastric Cancer 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Gastric Cancer 1Advanced Gastric Adenocarcinoma 1Advanced Esophagus Cancer 1Adenocarcinoma of Lung 1

Interventions

Oxaliplatin 10Fluorouracil 6Irinotecan 5Docetaxel 5Capecitabine 5tislelizumab 4S 1 (combination) 4Paclitaxel 4Endoscopic Mucosal Resection 4XELOX 3Levoleucovorin 3Laparoscopy 3Folfox protocol 3sintilimab 2apatinib 2Proton Pump Inhibitors 2Gastroenterostomy 2Gastrectomy 2Clarithromycin 2Chemotherapy, Adjuvant 2Amoxicillin 2vactosertib 1titanium silicide 1pembrolizumab 1lenvatinib 1durvalumab 1bismuth tripotassium dicitrate 1anlotinib 1Trastuzumab 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Stomach Neoplasms × apatinib × Clear all
NCT02697838 2018-10-17

Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
20 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03599778 2018-07-26

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Anhui Provincial Hospital

Phase 1/2 Unknown
52 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡